Abraxane 5 mg/ml powder for dispersion for infusion., Onivyde pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion, Fluorouracil Accord 50 mg/ml šķīdums injekcijām vai infūzijām, CALCIUM FOLINATE , GEMCITABINE ACCORD 100 mg/ml, solution à diluer pour perfusion, Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
D-US-60010-001
Phase 3 small_molecule active
Quick answer
Abraxane 5 mg/ml powder for dispersion for infusion., Onivyde pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion, Fluorouracil Accord 50 mg/ml šķīdums injekcijām vai infūzijām, CALCIUM FOLINATE , GEMCITABINE ACCORD 100 mg/ml, solution à diluer pour perfusion, Oxaliplatin Accord 5 mg/ml Konzentrat zur Herstellung einer Infusionslösung for Metastatic Pancreatic Adenocarcinoma is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Metastatic Pancreatic Adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active